Evidence map›Paper›PMID 36978916›Full record

ReviewAntioxidants (Basel, Switzerland)2023

A Scientometric Study to a Critical Review on Promising Anticancer and Neuroprotective Compounds: Citrus Flavonoids.

Mingyang Qiu, Wenlong Wei, Jianqing Zhang, Hanze Wang, Yuxin Bai, De-An Guo

Full text readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Sirtuins as Players in the Signal Transduction ofInternational journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mingyang QiuCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.ORCID 0000-0002-5254-5489
Wenlong WeiShanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Jianqing ZhangShanghai Research Center for Modernization of Traditional Chinese Medicine, National Engineering Research Center of TCM Standardization Technology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Hanze WangCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.ORCID 0000-0002-2447-170X
Yuxin BaiCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.
De-An GuoCollege of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China.

Funding

Key-Area Research and Development Program of Guangdong Province 2020B1111110007Key Program of National Natural Science Foundation of China 82130111National Natural Science Foundation of China 82003938National Natural Science Foundation of China 82003940National Natural Science Foundation of China 82104385Qi-Huang Chief Scientist Project of National Administration of Traditional Chinese Medicine (2020) 2020Sanming Project of Medicine in Shenzhen SZZYSM202106004
6 · The paper itself

Abstract

Flavonoids derived from citrus plants are favored by phytomedicinal researchers due to their wide range of biological activities, and relevant studies have been sustained for 67 years (since the first paper published in 1955). In terms of a scientometric and critical review, the scientometrics of related papers, chemical structures, and pharmacological action of citrus flavonoids were comprehensively summarized. The modern pharmacological effects of citrus flavonoids are primarily focused on their anticancer activities (such as breast cancer, gastric cancer, lung cancer, and liver cancer), neuroprotective effects (such as anti-Alzheimer's disease, Parkinson's disease), and metabolic diseases. Furthermore, the therapeutic mechanism of cancers (including inducing apoptosis, inhibiting cell proliferation, and inhibiting cancer metastasis), neuroprotective effects (including antioxidant and anti-inflammatory), and metabolic diseases (such as non-alcoholic fatty liver disease, type 2 diabetes mellitus) were summarized and discussed. We anticipate that this review could provide an essential reference for anti-cancer and neuroprotective research of citrus flavonoids and provide researchers with a comprehensive understanding of citrus flavonoids.

Indexed as

anti-cancercitrus flavonoidsmechanism of actionneuroprotectionscientometric analysis

Identifiers

PMID36978916
PMCPMC10045114

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read9
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.